Gizmodo: Makers of Ozempic and Mounjaro Sued Over Allegedly 'Downplaying' Severe Side Effects https://gizmodo.com/makers-ozempic-mounjaro-sued-downplay-side-effects-1850704899 #glucagonlikepeptide1receptoragonist #antiobesitymedication #glucagonlikepeptide1 #healthmedicalpharma #elilillyandcompany #jaclynbjorklund #peptidehormones #gastroparesis #tirzepatide #semaglutide #novonordisk #elililly #diabetes

Despite exuberance about the potential of #tirzepatide, NICE says nope, they will not yet endorse its use in the NHS. "Promising, but more info needed on outcomes and #CostEffectiveness."
https://conscienhealth.org/2023/06/nice-says-nope-to-tirzepatide/

#Tirzepatide may be on a glide path for an indication in #obesity and Lilly seems confident of proving superiority in a head-to-head study. Better options for obesity care lie ahead.
https://conscienhealth.org/2023/04/is-mounjaro-gliding-toward-an-obesity-approval/

The ‘King Kong’ of #WeightLoss Drugs Is Coming

“He said he had nicknamed #Ozempic, the drug from #Lilly’s rival #NovoNordisk, the “gorilla” because it had been the most potent #GLP-1 containing drug to that point. “But #tirzepatide is really a King Kong”

#Mounjaro #Obesity #GIP #Wegovy #Semaglutide
#AppleNews: https://apple.news/AKVMN_WjjTG-RnP7c_O_qSg

https://on.wsj.com/3K726Kr

Profits will be enormous - it's a lifetime drug. What will it do to Medicaid & Medicare?

#Tirzepatide could become the best-selling drug of all time. Annual sales of could hit a record $48 billion

the drugmaker could price it similarly to Wegovy, is $1,500 for a month and Saxenda, about $1,350 month

Obesity is considered a chronic illness, and like any other chronic illnesses, most patients are expected to take the medication for their entire lives

#Obesity #pharma

https://www.nbcnews.com/health/health-news/weight-loss-drug-affordability-rcna60422

We hear that Lilly is thinking about a separate brand of #tirzepatide for #obesity. This subtly reinforces the idea that obesity is a trivial, cosmetic indication. Bad idea.
https://conscienhealth.org/2022/11/brands-that-keep-obesity-separate-and-unequal/

RT @MichaelAlbertMD@twitter.com

People are excited about financially impacting Eli Lilly’s insulin business when Lilly has been gearing up to replace it with a far more effective drug that will likely be the biggest blockbuster drug of all time. #tirzepatide

🐦🔗: https://twitter.com/MichaelAlbertMD/status/1591228807062511616